The gene therapy sector is at the forefront of transforming healthcare by offering treatments that target diseases at their genetic root. These companies are pioneering approaches that promise to cure or significantly ameliorate conditions once deemed incurable.
As this sector continues to innovate and secure regulatory approvals, adding fundamentally sound gene therapy stocks such as Pfizer Inc. (PFE), Sanofi (SNY), and Novartis AG (NVS) to your portfolio could be wise.
